Home › Trial NCT06213519
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis
- Trial IDNCT06213519
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorSichuan University
- Enrollment69
- Start date2024-02-20
- ConditionsPeritoneal Metastases · Gastric Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.